MET kinase-IN-2
MET kinase-IN-2 is a potent, selective, orally bioavailable MET kinase inhibitor with an IC50 of 7.4 nM. MET kinase-IN-2 has antitumor activity[1].
Product Specifications
CAS Number
[2101241-90-9]
UNSPSC
12352005
Target
C-Met/HGFR
Type
Reference compound
Related Pathways
Protein Tyrosine Kinase/RTK
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/met-kinase-in-2.html
Purity
98.39
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
O=C1C(C2=CC=CC=C2)=CNC3=C1C(NC4=CC=C(OC5=CC=NC6=CC(OCC(C)(O)C)=CC=C56)C(F)=C4)=NC=C3
Molecular Formula
C33H27FN4O4
Molecular Weight
562.59
References & Citations
[1]Chen T, et al. Discovery of 1,6-naphthyridinone-based MET kinase inhibitor bearing quinoline moiety as promising antitumor drug candidate. Eur J Med Chem. 2020;192:112174.
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, protect from light, stored under nitrogen)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
NSL2311Hu 96 Tests
Human 5' ,3' -nucleotidase, cytosolic (NT5C) ELISA Kit
Sign In for Pricing
View Details 
TA371760 100 µL
alpha Glucosidase II (GANAB) Rabbit Polyclonal Antibody
Sign In for Pricing
View Details 
K3529304 1.0 µg DNA
Plod2 sgRNA CRISPR Lentivector (Mouse) (Target 3)
Sign In for Pricing
View Details bsm-62256R-BF680 100 µL
Stanniocalcin 1 Recombinant Antibody, AbBy Fluor™ 680 Conjugated
Sign In for Pricing
View Details